Mitochondria-Targeting Therapies
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
160
NCT04651634
MIT-001 for Prevention of CCRT-Induced OM in HNSCC Patients
Phase: Phase 2
Role: Lead Sponsor
Start: Jun 21, 2021
Completion: Dec 31, 2025
NCT05493800
Evaluate the Safety and Efficacy for Oral Mucositis Prevention of MIT-001 in Auto HSCT
Start: Feb 1, 2022
Completion: Dec 30, 2024
NCT05389696
Clinical Trial to Evaluate Pharmacokinetic Characteristics of MIT-001 After SC Administration in Healthy Subjects
Phase: Phase 1
Start: May 13, 2022
Completion: Apr 28, 2023
Loading map...